Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus



The severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) disease (COVID-19) pandemic has caused millions of deaths worldwide…

Read here

Previous Drug hunters uncloak the non-coding ‘hidden’ genome Drug hunters uncloak the non-coding ‘hidden’ genome
October 7, 2021
Next Nucleome Therapeutics Announces Formation of Advisory Board Nucleome Therapeutics Announces Formation of Advisory Board
February 11, 2022